<DOC>
	<DOCNO>NCT00915096</DOCNO>
	<brief_summary>The purpose study assess prospective series patient high tumor burden follicular lymphoma treat R-CHOP , predictive value [ 18F ] -FDG PET perform ( 4 treatment ) , end first-line treatment progression-free survival 2 year .</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) -Scan Evaluation High Tumor Burden Follicular Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<criteria>Patients malignant nonHodgkin follicular lymphoma ( histologic grade 1 3 WHO classification ) , histologically confirm , Patients previously treat disease , Introducing one criterion high tumor burden , Patients age 18 80 year , Patients whose ECOG condition ≤ 2 , Patients whose haematological function adequate within 28 day precede treatment ( Hemoglobin ≥8,0g/dl ; Neutrophils ≥1,5e9/L , Platelets ≥100e9/L ) , Patient PET examination less month start chemotherapy . Patients lymphoma already transform treated disease , Patients whose lymphoma stage 3b , Patients impaired central nervous system , Patients regularly take corticosteroid 4 week precede treatment ( unless dose administer equivalent ≤20 mg/day prednisone ) . Patients undergone major surgery 28 day precede inclusion , Patients low kidney and/or liver function , Patients HIV + infection HBV HCV le 4 week . Patients hepatitis B serology positive unless sign relate vaccination , Patients whose life expectancy ≤ 6 month , Patients sensitive allergic murine product , Patients participate another clinical trial 30 day precede recording , Patients medical problem psychological succeptibles interfere study , Patients adult supervision .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Follicular Lymphoma</keyword>
	<keyword>PET</keyword>
	<keyword>GELA</keyword>
</DOC>